C WorldWide Group’s Regeneron Pharmaceuticals REGN Stock Holding History

C WorldWide Group’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-350	Closed	-$128K	–	135
2016 Q4	$128K	Sell	350 -3,100	-90%	-$1.18M	﹤0.01%	122
2016 Q3	$1.39M	Buy	3,450 +520	+18%	+$209K	0.02%	102
2016 Q2	$1.02M	Hold	2,930	–	–	0.02%	97
2016 Q1	$1.06M	Hold	2,930	–	–	0.02%	97
2015 Q4	$1.59M	Sell	2,930 -490	-14%	-$265K	0.03%	90
2015 Q3	$1.59M	Buy	3,420 +70	+2%	+$37.6K	0.03%	91
2015 Q2	$1.71M	Hold	3,350	–	–	0.02%	93
2015 Q1	$1.51M	Sell	3,350 -250	-7%	-$106K	0.02%	91
2014 Q4	$1.48M	Sell	3,600 -450	-11%	-$177K	0.02%	78
2014 Q3	$1.43M	Buy	+4,050	New	+$1.36M	0.02%	85

Other funds holding REGN

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return

C WorldWide Group's REGN Position: Q1 2017 in Review

C WorldWide Group sold out of Regeneron Pharmaceuticals (REGN) in Q1 2017, closing a stake of 350 shares — an estimated $128K sold.

C WorldWide Group first reported a position in REGN in Q3 2014 and held it in 10 quarters. The position peaked at $1.71M in Q2 2015. 579 funds tracked by Wall St. Rank hold REGN as of Q1 2017.

C WorldWide Group reported no remaining Regeneron Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
C WorldWide Group sold 350 Regeneron Pharmaceuticals shares in Q1 2017, an estimated $128K.
C WorldWide Group first reported a position in Regeneron Pharmaceuticals in Q3 2014 and held it in 10 quarters.
C WorldWide Group's Regeneron Pharmaceuticals position peaked at $1.71M in Q2 2015.
579 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2017.

Based on C WorldWide Group's 13F filing for Q1 2017, filed 1 May 2017.